Sheffield Institute for
Translational Neuroscience

Promising MND drug helps slow disease progression and benefits patients physically

World Parkinson's Day - UK Parkinson’s Clinical Study Group

Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases

Frequent strenuous exercise increases the chance of developing MND in genetically at risk individuals

​​​​​​​New gene therapy innovation centre to advance scientific discoveries into life-changing treatments

Sheffield scientists awarded £1.2 million to design Parkinson’s drug

New study suggests genetic testing could be appropriate for all motor neuron disease (MND) patients whether or not they have a family history of the disease

SITraN: Ten Years of Impact

New partnership to take potential treatment for motor neurone disease (MND) into clinical trials

Encouraging early study for investigational drug in people with motor neurone disease